Safety parameters included overall mortality, asymptomatic ICH,
symptomatic ICH, fatal ICH, and other serious adverse events
(SAEs). Causes of death were assessed by the local investigator. All
patients who died and had any type of ICH were reviewed by the
blinded independent data safety monitoring board (DMSB) on an
ongoing basis.